Table 5.
Sampling (period) |
Assessment of BMS | Sex predominant | Age distribution (years old) |
Prevalence | |
---|---|---|---|---|---|
Su. et al. present study (Taiwan) |
Nationwide population (2004–2013) |
Insurance dataset | Female | Mean age: 47.85 Mean age: male 46.26 Mean age: female 48.97 Significant: > 30–39 years old group |
Total: 2.76 (per 104) Male: 2.31 (per 104) Female: 3.21 (per 104) |
Tammiala-Salonen et al.13 (Finnish) |
600 volunteers (289 men and 311 women) (10-year observation) |
Questionnaires Clinical exam | Female |
Mean age: male 51 Mean age: female 57 Significant: female > 30–39 years old group |
Total: 1–15% (dependent on the criteria for BMS) |
Bergdahl & Bergdahl14 (Sweden) | 1427 volunteers (669 men and 758 women) (year no shown) |
Questionnaires Clinical exam | Female |
Mean age: male 59.1 Mean age: female 56.9 Significant: > 30–39 years old group |
Total: 3.7%; Male: 1.6% Female: 5.5% |
Kohorst et al.15 (USA) |
Residents of Olmsted County (2000–2009) |
Clinical exam | Female | Mean age: 59.4 Significant: > 50 years old group |
Total: 10.33 (per 104) Male: 3.40 (per 104) Female: 16.95 (per 104) |